PresentationLadies and gentlemen, please stand by. Ladies and gentleman, please remain on line, your conference will begin shortly.I would now like to hand the conference over to your speaker today, Ramses Erdtmann, President and Chief Operating Officer. Please go ahead.Ramses ErdtmannCo-Founder, President, COO & Director Perfect. Okay. All the other speakers that have dialed in, we're going to go live. Maybe you can let Juan Pablo now. Okay. Thank you, operator, and welcome, everyone, to this conference ca ...

会议基本信息 - 本次会议为Biomea公司电话会议 [3] - 会议由公司总裁兼首席运营官Ramses Erdtmann主持 [1][3] 临床研究进展 - 公司公布了COVALENT-111研究的52周结果 [3] - 该研究是一项随机双盲、安慰剂对照的二期临床试验 [3] - 试验旨在评估icovamenib在二型糖尿病患者中的安全性和耐受性 [3] - 试验同时包含探索性疗效终点 [3]